Skip to main content

Table 1 Baseline characteristics of 30 patients

From: Treatment outcomes of oral sitafloxacin in acute complicated urinary tract infection and pyelonephritis

Parameters

Number (%)

Patients’ parameters

Sex

 

 Male

10 (33 %)

 Female

20 (67 %)

Age, years, mean ± SD

49 ± 13

Body weight, kg, mean ± SD

62 ± 12

Laboratory parameters

Hematocrit, mg %, mean ± SD

37 ± 6

White blood cells count, cells/mm3, mean ± SD

11,340 ± 5,496

Platelet, cells/mm3, mean ± SD

305,433 ± 115,971

Neutrophil, %, mean ± SD

75 ± 14

ESR, millimeters per hour, mean ± SD

46 ± 29

C-reactive protein, mg/L, mean ± SD

35 ± 31

BUN, mg/dl, mean ± SD

15 ± 11

Creatinine, mg/dl, mean ± SD

1.13 ± 0.76

Aspatate aminotransferase, U/L, mean ± SD

33 ± 34

Alanine aminotransferase, U/L, mean ± SD

37 ± 45

Total bilirubin, mg/dl, mean ± SD

1.4 ± 3.9

Albumin, mg/dl, mean ± SD

4.0 ± 0.5

Urinary tract infection (UTI) diagnosis

 Acute pyelonephritis

21 (70 %)

 Complicated UTI

9 (30 %)

  Stroke with neurogenic bladder

3

  Catheter-related UTI

2

  Ureteric stone with hydronephrosis

2

  UTI in men

2

Positive urine culture

22 (73 %)

 E. coli

11

 ESBL producing E. coli

4

 ESBL producing E. coli + ESBL producing K. pneumoniae

1

 Enterobacter cloacae

1

 Enterococcus fecalis

1

 Klebseilla pneumoniae

1

 Morganella morganii

1

 MRSA

1

 Coagulase negative Staphylococcus

1

Sensitivity to sitafloxacin, n = 22

 

 Sensitive

19 (86 %)

 Intermediate

1 (5 %)

 Resistant

2 (9 %)